Holdings of Flagship Pioneering, LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 5 in 1 countries
- Top ten
- 100.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Generate Biomedicines Inc | 62,673,117 | 783.4M $ | |
| 2 | Moderna Inc | 4,632,149 | 235.3M $ | |
| 3 | Sana Biotechnology Inc | 25,001,856 | 72M $ | |
| 4 | Foghorn Therapeutics Inc | 12,674,120 | 60.6M $ | |
| 5 | Seres Therapeutics Inc | 1,155,850 | 10.3M $ |
Sector breakdown
- Health care 20.3 %
- Unattributed 79.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 100.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 5 | 1.2B $ | 100.00 % |
Cite this page
Titelia. "Holdings of Flagship Pioneering, LLC". https://titelia.com/en/funds/US13F1400240